Live data from Hacker News

Lung Cancer Patients Live Longer with Immune Therapy

nytimes.com

11–20 of 79 posts

Re: Lung Cancer Patients Live Longer with Immune Therapy

#11

Someone close passed away from lung cancer last year. He received immune therapy (keytruda), and while it may work wonders for others, it comes with drawbacks; My main issue was that it takes 4 to 5 treatments (with weeks between each treatment) before you even really know if it worked or not. This is valuable time that could be used to treat the cancer with chemo (which admittedly has way worse side effects than key…

Are there numbers that say what the success rate of immuni therapy is?

Re: Lung Cancer Patients Live Longer with Immune Therapy

#12
> After a median follow-up of 10.5 months, the estimated rate of overall survival at 12 months was 69.2% in the pembrolizumab-combination group versus 49.4% in the placebo-combination group.

Seriously groundbreaking. This is a once-in-a-decade paper. [1]

[1] http://www.nejm.org/doi/full/10.1056/NEJMoa1801005?query=fea...

Re: Lung Cancer Patients Live Longer with Immune Therapy

#13
post #11

Someone close passed away from lung cancer last year. He received immune therapy (keytruda), and while it may work wonders for others, it comes with drawbacks; My main issue was that it takes 4 to 5 treatments (with weeks between each treatment) before you even really know if it worked or not. This is valuable time that could be used to treat the cancer with chemo (which admittedly has way worse side effects than key…

Are there numbers that say what the success rate of immuni therapy is?

It sort of depends on what you define as success. The goal was never to "cure" the cancer, rather, to shrink the tumor.

I hesitate to assign an exact percentage to the effectiveness since there are so many factors to consider, but I remember Keytruda being reported to shrink tumors in less than a third of patients who took it.

Re: Lung Cancer Patients Live Longer with Immune Therapy

#15
post #11

Earlier quoted context omitted.

Are there numbers that say what the success rate of immuni therapy is?

It sort of depends on what you define as success. The goal was never to "cure" the cancer, rather, to shrink the tumor. I hesitate to assign an exact percentage to the effectiveness since there are so many factors to consider, but I remember Keytruda being reported to shrink tumors in less than a third of patients who took it.

The goal is to cure, from the article, quoting the head of lung at Yale:

> “Chemotherapy has limitations. Immunotherapy has the ability to cure. I lead the Yale lung team. We have patients on these immunotherapies alive more than eight years.”

Re: Lung Cancer Patients Live Longer with Immune Therapy

#16

The prohibitively expensive nature of any immunotherapy leaves me profoundly skeptical of its practical usefulness. $100,000/year? That's more than twice the median income in this country. Is it simply that expensive to get mabs from animals, is drug development disgustingly expensive, or is there unbounded greed in pharmaceutical companies?

More then last 2 than the first one. Getting money from investors is much harder than getting MAbs from animals. Probably more gruesome, too. Also greed is not just the Pharma. Some Hospitals/physicians use Clinical Trials as a profit center, and see Pharma as a bottomless pit of cash-- its a bit of a vicious circle.

Re: Lung Cancer Patients Live Longer with Immune Therapy

#17

The prohibitively expensive nature of any immunotherapy leaves me profoundly skeptical of its practical usefulness. $100,000/year? That's more than twice the median income in this country. Is it simply that expensive to get mabs from animals, is drug development disgustingly expensive, or is there unbounded greed in pharmaceutical companies?

PhDs that have dedicated their lives to specializing in specific cancers, failed drugs, research that leads nowhere, failed clinical trials because of XYZ. It's all highly specialized. And if done with a rigorous protocol, it's all expensive.

You're not doing a lifetime of cancer research in hopes that you earn an average salary.

For the company, if you finally get somewhere with a drug that is affective, you have to try and recoup your investment. How else do you fund future research?

Re: Lung Cancer Patients Live Longer with Immune Therapy

#18
post #15

Earlier quoted context omitted.

It sort of depends on what you define as success. The goal was never to "cure" the cancer, rather, to shrink the tumor. I hesitate to assign an exact percentage to the effectiveness since there are so many factors to consider, but I remember Keytruda being reported to shrink tumors in less than a third of patients who took it.

The goal is to cure, from the article, quoting the head of lung at Yale: > “Chemotherapy has limitations. Immunotherapy has the ability to cure. I lead the Yale lung team. We have patients on these immunotherapies alive more than eight years.”

I am sorry, that wasn't clear; That was the goal in the specific case of my family-member. The tumors would never fully disappear, and he would likely need more treatments later on.

Re: Lung Cancer Patients Live Longer with Immune Therapy

#19

I’m now 5.5 years post-treatment with immunotherapy for Stage IV melanoma and have had no evidence of disease for over four years. When immunotherapy works, it can be impressive. For me, my treatment (adoptive cell therapy using tumor infiltrating lymphocytes) used my own white blood cells (130 billion in lab-selected and expanded form) to overwhelm the mutated cancer cells. It was a one-time treatment (over 3-4 week…

That’s great news both for you and for all of us.

I hope all patients that would benefit from this treatment will have access to it, to save their lives and to validate and improve the therapy for all those to come

Re: Lung Cancer Patients Live Longer with Immune Therapy

#20
>They cost more than $100,000 a year, can have serious side effects and help only some patients, generally fewer than half.

Fuck you and the fuck the US healthcare system. Daddy or mama gets to live a few more years, but it will put the family into lifelong debt. I'll say it again, fuck you.

Post reply on HN